• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Gerontol A Biol Sci Med Sci . Altered blood cell traits underlie a major genetic locus of severe COVID-19

tetano

Editor, Senior Moderator
J Gerontol A Biol Sci Med Sci


. 2021 Feb 2;glab035.
doi: 10.1093/gerona/glab035. Online ahead of print.
Altered blood cell traits underlie a major genetic locus of severe COVID-19


Jingqi Zhou[SUP] 1 2 [/SUP], Yitang Sun[SUP] 1 [/SUP], Weishan Huang[SUP] 3 4 [/SUP], Kaixiong Ye[SUP] 1 5 [/SUP]



Affiliations

Abstract

Background: The genetic locus 3p21.31 has been associated with severe coronavirus disease 2019 (COVID-19), but the underlying pathophysiological mechanism is unknown.
Methods: To identify intermediate traits associated with the 3p21.31 locus, we first performed a phenome-wide association study (PheWAS) with 923 phenotypes in 310,999 European individuals from the UK Biobank. For genes potentially regulated by the COVID-19 risk variant, we examined associations between their expression and the polygenic score (PGS) of 1,263 complex traits in a meta-analysis of 31,684 blood samples. For the prioritized blood cell traits, we tested their associations with age and sex in the same UK Biobank sample.
Results: Our PheWAS highlighted multiple blood cell traits to be associated with the COVID-19 risk variant, including monocyte count and percentage (p = 1.07?10 -8, 4.09?10 -13), eosinophil count and percentage (p = 5.73?10 -3, 2.20?10 -3), and neutrophil percentage (p = 3.23?10 -3). The PGS analysis revealed positive associations between the expression of candidate genes and genetically predicted counts of specific blood cells: CCR3 with eosinophil and basophil (p = 5.73?10 -21, 5.08?10 -19); CCR2 with monocytes (p = 2.40?10 -10); and CCR1 with monocytes and neutrophil (p = 1.78?10 -6, 7.17?10 -5). Additionally, we found that almost all examined white blood cell traits are significantly different across age and sex groups.
Conclusions: Our findings suggest that altered blood cell traits, especially those of monocyte, eosinophil, and neutrophil, may represent the mechanistic links between the genetic locus 3p21.31 and severe COVID-19. They may also underlie the increased risk of severe COVID-19 in older adults and men.

Keywords: COVID-19; blood cells; eosinophil; monocyte; phenome-wide association study.
 
Back
Top Bottom